Objectives This narrative review describes the clinical features of apathy and depression in
individuals with neurocognitive disorders (NCDs), with the goal of differentiating the two …

The amygdala was highlighted as an early site for neurofibrillary tau tangle pathology in
Alzheimer's disease in the seminal 1991 article by Braak and Braak. This knowledge has …

Background and Objectives Mild cognitive impairment (MCI) is an at-risk state for dementia;
however, not all individuals with MCI transition to dementia, and some revert to normal …

Objective To compare the utility of the Mild Behavioral Impairment-Checklist (MBI-C) and
Neuropsychiatric Inventory Questionnaire (NPI-Q) to capture NPS in subjective cognitive …

Background Disease-modifying drug use necessitates better Alzheimer disease (AD)
detection. Mild cognitive impairment (MCI) leverages cognitive decline to identify the risk …

Introduction: Simple markers are required to recognize older adults at higher risk for
neurodegenerative disease. Mild behavioural impairment (MBI) and plasma β-amyloid (Aβ) …

Background and Objectives Plasma phosphorylated tau at threonine 181 (p-tau181), a well-
validated marker of Alzheimer disease (AD) pathologic change, could be a more efficient …

Objectives: Dementia assessment includes cognitive and behavioral testing with informant
verification. Conventional testing is resource-intensive, with uneven access. Online …

Background Mild behavioral impairment (MBI) is a syndrome that uses later‐life emergent
and persistent neuropsychiatric symptoms (NPS) to identify a group at high risk for incident …

Introduction Mild behavioral impairment (MBI) is characterized by later‐life emergence of
neuropsychiatric symptoms. Investigating its relationship with progression to Alzheimer's …